The market is driven by the growing adoption of NGS, increasing affordability of DNA sequencing, and expanding applications of DNA sequencing
1h Free Analyst Time
The DNA sequencing market is forecast to grow by USD 17.34 billion during 2023-2028, accelerating at a CAGR of 20.01% during the forecast period. The report on the dna sequencing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing adoption of ngs, increasing affordability of DNA sequencing, and expanding applications of DNA sequencing.
The DNA sequencing market is segmented as below:
By End-user
- Academic research
- Clinical research
- Hospitals and clinics
- Pharmaceutical and biotechnology companies
By Solution
- Products
- Services
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the DNA sequencing market covers the following areas:
- DNA sequencing market sizing
- DNA sequencing market forecast
- DNA sequencing market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Solution
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global DNA sequencing market: 10X Genomics Inc., Abbott Laboratories, Agilent Technologies Inc., Azenta Inc., Becton Dickinson and Co., BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Danaher Corp., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Illumina Inc., Laboratory Corp. of America Holdings, Macrogen Inc., Merck KGaA, Pacific Biosciences of California Inc., PerkinElmer Inc., QIAGEN NV, SeqLL Inc., Tecan Trading AG, and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is emergence of third-generation sequencing methods."
According to the report, one of the major drivers for this market is the growing adoption of NGS.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 10X Genomics Inc.
- Abbott Laboratories
- Agilent Technologies Inc.
- Azenta Inc.
- Becton Dickinson and Co.
- BGI Genomics Co. Ltd.
- Bio Rad Laboratories Inc.
- Danaher Corp.
- Eurofins Scientific SE
- F. Hoffmann La Roche Ltd.
- Illumina Inc.
- Laboratory Corp. of America Holdings
- Macrogen Inc.
- Merck KGaA
- Pacific Biosciences of California Inc.
- PerkinElmer Inc.
- QIAGEN NV
- SeqLL Inc.
- Tecan Trading AG
- Thermo Fisher Scientific Inc.
